MEDLINE INC (MDLN)
NASDAQHealth CareMedical - Instruments & SuppliesSnapshot 2026-11-05
$39.76-1.46%
Close 2026-11-05 · 1-day change
NASDAQHealth CareMedical - Instruments & SuppliesSnapshot 2026-11-05
QuarterlyIQ Insights · MDLN
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | |
|---|---|---|---|---|
| Revenues | ||||
| Revenues | 30,680.0 | 28,432.0 | 25,507.0 | 23,231.0 |
| Total Revenues | 30,680.0 | 28,432.0 | 25,507.0 | 23,231.0 |
| Cost of Revenues | 22,785.0 | 20,914.0 | 18,531.0 | 17,346.0 |
| Gross Profit | 7,895.0 | 7,518.0 | 6,976.0 | 5,885.0 |
| Operating Expenses & Income | ||||
| Selling, General & Admin | 5,047.0 | 4,524.0 | 4,108.0 | 3,867.0 |
| R&D Expenses | — | 80.0 | 67.0 | 60.0 |
| Other Operating Expenses, Total | (401.0) | (78.0) | (37.0) | (106.0) |
| Operating Income | 1,742.0 | 2,212.0 | 2,146.0 | 1,250.0 |
| Earnings from Continuing Operations | ||||
| Interest Expense | — | 945.0 | — | — |
| Interest & Investment Income | 159.0 | 133.0 | 280.0 | 237.0 |
| Other Non-Operating Income / Expenses | (624.0) | (964.0) | (900.0) | (986.0) |
| EBT, Incl. Unusual Items | 1,118.0 | 1,248.0 | 1,246.0 | 264.0 |
| Income Tax Expense | 242.0 | 91.0 | 46.0 | 30.0 |
| Net Income | ||||
| Minority Interest | 310.0 | (2.0) | — | — |
| Net Income | 1,156,730.0 | 1,159.0 | 1,163.0 | 234.0 |
| Per Share | ||||
| Basic EPS | 1,319.76 | (0.01) | — | — |
| Diluted EPS | 878.70 | (0.01) | — | — |
| Revenue per Share | 23.31 | — | — | — |
| Basic Weighted Avg Shares | 876.5 | 810.0 | — | — |
| Diluted Weighted Avg Shares | 1,316.4 | 810.0 | — | — |
| Supplemental | ||||
| EBITDA | — | 3,223.0 | 3,123.0 | 2,201.0 |
| EBIT | 1,742.0 | 2,212.0 | 2,146.0 | 1,250.0 |
| Effective Tax Rate | 21.6% | — | 3.7% | 11.4% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.